MHRA grants first approval via the new International Recognition Procedure in 30 days
Launched in January 2024, International Recognition Procedure aims to further help bring life-saving new medicines to UK patients without delay.
Read the press release from Medicines and Healthcare products Regulatory Agency published on 1st March 2024.
OpenEdition vous propose de citer ce billet de la manière suivante :
lsgilbert (21 mai 2024). MHRA grants first approval via the new International Recognition Procedure in 30 days. ELSIBI. Consulté le 16 janvier 2025 à l’adresse https://doi.org/10.58079/11ozl